TY - JOUR
T1 - Haploinsufficiency of the NF-κB1 Subunit p50 in Common Variable Immunodeficiency
AU - Fliegauf, Manfred
AU - L Bryant, Vanessa
AU - Frede, Natalie
AU - Slade, Charlotte
AU - Woon, See-Tarn
AU - Lehnert, Klaus
AU - Winzer, Sandra
AU - Bulashevska, Alla
AU - Scerri, Thomas
AU - Leung, Euphemia
AU - Jordan, Anthony
AU - Keller, Baerbel
AU - de Vries, Esther
AU - Cao, Hongzhi
AU - Yang, Fang
AU - Schäffer, Alejandro A
AU - Warnatz, Klaus
AU - Browett, Peter
AU - Douglass, Jo
AU - Ameratunga, Rohan V
AU - van der Meer, Jos W M
AU - Grimbacher, Bodo
N1 - Copyright © 2015 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
PY - 2015
Y1 - 2015
N2 - Common variable immunodeficiency (CVID), characterized by recurrent
infections, is the most prevalent symptomatic antibody deficiency. In
∼90% of CVID-affected individuals, no genetic cause of the disease has
been identified. In a Dutch-Australian CVID-affected family, we
identified a NFKB1 heterozygous splice-donor-site mutation (c.730+4A>G), causing in-frame skipping of exon 8. NFKB1
encodes the transcription-factor precursor p105, which is processed to
p50 (canonical NF-κB pathway). The altered protein bearing an internal
deletion (p.Asp191_Lys244delinsGlu; p105ΔEx8) is degraded, but is not
processed to p50ΔEx8. Altered NF-κB1 proteins were also undetectable in a
German CVID-affected family with a heterozygous in-frame exon 9
skipping mutation (c.835+2T>G) and in a CVID-affected family from New
Zealand with a heterozygous frameshift mutation (c.465dupA) in exon 7.
Given that residual p105 and p50—translated from the non-mutated
alleles—were normal, and altered p50 proteins were absent, we conclude
that the CVID phenotype in these families is caused by NF-κB1 p50
haploinsufficiency.
AB - Common variable immunodeficiency (CVID), characterized by recurrent
infections, is the most prevalent symptomatic antibody deficiency. In
∼90% of CVID-affected individuals, no genetic cause of the disease has
been identified. In a Dutch-Australian CVID-affected family, we
identified a NFKB1 heterozygous splice-donor-site mutation (c.730+4A>G), causing in-frame skipping of exon 8. NFKB1
encodes the transcription-factor precursor p105, which is processed to
p50 (canonical NF-κB pathway). The altered protein bearing an internal
deletion (p.Asp191_Lys244delinsGlu; p105ΔEx8) is degraded, but is not
processed to p50ΔEx8. Altered NF-κB1 proteins were also undetectable in a
German CVID-affected family with a heterozygous in-frame exon 9
skipping mutation (c.835+2T>G) and in a CVID-affected family from New
Zealand with a heterozygous frameshift mutation (c.465dupA) in exon 7.
Given that residual p105 and p50—translated from the non-mutated
alleles—were normal, and altered p50 proteins were absent, we conclude
that the CVID phenotype in these families is caused by NF-κB1 p50
haploinsufficiency.
U2 - 10.1016/j.ajhg.2015.07.008
DO - 10.1016/j.ajhg.2015.07.008
M3 - Article
C2 - 26279205
SN - 0002-9297
VL - 97
SP - 389
EP - 403
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 3
ER -